Drug Trial Radar · NCT06684041
A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Jul 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Nov 9, 2024
Primary completion
Apr 7, 2025
Study completion Apr 7, 2025
Sponsor
- Lead sponsor
- Chengdu Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This was a randomized, double-blind, single-dose, placebo-controlled phase I clinical trial. This study plans to conduct three dose groups of dose 1, dose 2, and dose 3. A total of 32 healthy subjects were planned to be enrolled.
Conditions
- Hemolytic Anemia
Interventions
HRS-5965 capsuleDrug
HRS-5965 capsule
HRS-5965 capsule placeboDrug
HRS-5965 capsule placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of subjects with adverse events (AEs)Time frame: Baseline up to seven days after the last dosing.
- QTcF: Baseline and placebo-adjusted QTcF after oral HRS-5965 capsulesTime frame: Baseline up to 24 hours after dosing.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongnan hospital of Wuhan University
Wuhan, Hubei, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.